Oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: A case report

M. A. Ashburn; P. G. Fine; T. H. Stanley

Journal ArticleOPEN ACCESS

Oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: A case report

Ashburn M
Fine P
Stanley T

Anesthesiology (1989) 71(4) 615-617

DOI: 10.1097/00000542-198910000-00026

38Citations

12Readers

Cited by Powered by Scopus

View more at Scopus

Cite

CITATION STYLE

APA

Ashburn, M. A., Fine, P. G., & Stanley, T. H. (1989). Oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: A case report. Anesthesiology, 71(4), 615–617. https://doi.org/10.1097/00000542-198910000-00026

Readers over time

Readers' Seniority

Researcher 3

50%

PhD / Post grad / Masters / Doc 2

33%

Lecturer / Post doc 1

17%

Readers' Discipline

Medicine and Dentistry 4

44%

Biochemistry, Genetics and Molecular Bi... 2

22%

Business, Management and Accounting 2

22%

Chemistry 1

11%

Oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: A case report

Cited by Powered by Scopus

The fentanyl story

Oral transmucosal fentanyl citrate: Randomized, double-blinded, placebo- controlled trial for treatment of breakthrough pain in cancer patients

A survey of pain-related hospitalizations, emergency department visits, and physician office visits reported by cancer patients with and without history of breakthrough pain

Register to see more suggestions

Cite

Readers over time

Readers' Seniority

Readers' Discipline